Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bright Mountain Media, Inc.Bright Mountain Media Reports Mixed Q3 Results, Revenue Growth in 9-Month Period
Central Plains Bancshares, Inc.Central Plains Bancshares Reports Strong Asset Growth, Increased Revenue, and Strategic Developments
Dave Inc./DEDave Inc. Reports 41% Revenue Growth, Net Income Turnaround in Q3 2024
IMPACT BIOMEDICAL INC.Impact BioMedical Reports Significant Turnaround, Net Income of $4.2M in Q3 2024
WILLAMETTE VALLEY VINEYARDS INCWillamette Valley Vineyards Reports Modest Revenue Growth and Improved Profitability in Q3 2024
BATTALION OIL CORPBattalion Oil Reports Decline in Operating Revenues and Production Volumes, Net Income Turnaround in Q3 2024
IO Biotech, Inc.IO Biotech Reports Financial Results, Net Loss Increases 10.8% to $24M in Latest Quarter
DHI GROUP, INC.DHI Group Reports Decline in Revenue and Net Income for Q3 2024
Innovative Eyewear IncInnovative Eyewear Reports 14% Revenue Growth, Net Losses Continue Amid Rising Costs and Operating Expenses
Fold Holdings, Inc.FTAC Emerald Acquisition Corp. Reports Significant Financial Changes, Net Loss, and Merger Agreement with Fold, Inc.
Calumet, Inc. /DECalumet, Inc. Reports Significant Financial Challenges in Q3 2024, Net Loss of $100.6 Million
MACH NATURAL RESOURCES LPMach Natural Resources Reports 46% Revenue Growth, 66% Production Increase in Q3 2024
Xenetic Biosciences, Inc.Xenetic Biosciences Reports Stable Revenue, Continued Net Losses in Q3 2024
Rocket Companies, Inc.Rocket Companies Reports Mixed Q3 Results, Net Loss and Revenue Decline Amid Strategic Developments
Shift4 Payments, Inc.Shift4 Payments Reports 35% Revenue Growth, 56% Increase in End-to-End Payment Volume in Latest Quarter
GLEN BURNIE BANCORPGlen Burnie Bancorp Reports Mixed Financial Results for Third Quarter and Nine Months Ended September 30, 2024
BLUM HOLDINGS, INC.Blum Holdings Reports 181.7% Revenue Growth, Net Income Turnaround in Q3 2024
NCR Atleos CorpNCR Atleos Reports 1% Revenue Growth, 141% Increase in Net Income for Q3 2024
Acumen Pharmaceuticals, Inc.Acumen Pharmaceuticals Reports Net Loss, Decrease in Cash Reserves, and Increased Expenses in Q3 2024
CNH Industrial N.V.CNH Industrial Reports 22.3% Revenue Decline and 42.6% Net Income Drop in Q3 2024
MANNATECH INCMannatech Reports Decline in Financial Performance for Q3 and Nine Months of 2024
Autolus Therapeutics plcAutolus Therapeutics Reports Significant Financial Developments, Including Cash Increase and Net Loss in Q3 2024
Tempest Therapeutics, Inc.Tempest Therapeutics Reports Financial Results, Expands Leadership Team, and Advances Clinical Programs
OCTAVE SPECIALTY GROUP INCAmbac Financial Group Reports Net Loss, Revenue Growth, and Strategic Expansion in Q3 2024
iBio, Inc.iBio Reports Significant Financial Changes, Shifts Focus to Preclinical Pipeline Development